Teva Pharmaceutical to Replace CEO Kare Schultz - WSJ
Teva's Adderall Shortage Seen Continuing Into March (TEVA) - Bloomberg
Teva Poised to Face U.S. Charges in Drug Price-Fixing Probe - Bloomberg
US states accuse Teva and other drugmakers of colluding to inflate prices over 1,000%
Teva to Sell Assets Such as Women's Health Unit to Cut Debt - Bloomberg
Opioid Manufacturer Teva Pharmaceuticals Reaches $4B Global Settlement | Law.com
Teva Pharmaceuticals found to be responsible for its role in the opioid epidemic in New York State | CNN
America's Most Beloved Pharmaceutical Stock Is Israel's Teva - Bloomberg
The Pharma Job From Hell: Low Salary to Fix Sinking Giant Teva - Bloomberg
Teva, Allergan Ready To Pay $5B To Settle Lawsuits Related To Opioid Painkillers: Bloomberg
Teva Pharmaceuticals to pay New York $523 million to settle claims from its role in opioids crisis - ABC News
Teva makes $40B offer for Mylan
Teva Is Facing Adderall Supply Disruptions as Demand for ADHD Drug Soars - Bloomberg
Teva halts output at U.S. drug plant after FDA flags concerns | Reuters
Teva's Budding Blockbuster Drugs Lend Respite From Legal Concerns - Bloomberg
Teva, Units Held Liable for Fueling N.Y. Opioid Crisis - Bloomberg
Teva, Units Held Liable for Fueling N.Y. Opioid Crisis - Bloomberg
Zantac Cancer Case in US Settles for $500,000 (PRGO, TEVA) - Bloomberg
Teva Sees Adderall Supply Delays Continuing for 2-3 Months (1)
Teva Pharmaceutical Will Pay Over $4 Billion in Opioid Settlement - Bloomberg
The Pharma Job From Hell: Low Salary to Fix Sinking Giant Teva - Bloomberg
Teva to Sell Record $5 Billion of Sustainability-Linked Bonds - Bloomberg
Teva Pharmaceutical Will Pay Over $4 Billion in Opioid Settlement - Bloomberg
The Difficulties of Cloning a CEO - Bloomberg
Teva Pharma's Short Sellers Double Down as Legal Woes Drag On - Bloomberg
Teva Pharmaceutical: Value at Last - WSJ
